Postmarketing surveillance of telaprevir‐based triple therapy for chronic hepatitis C in Japan
M Shiraishi, I Umebayashi, H Matsuda… - Hepatology …, 2015 - Wiley Online Library
Aim An observational postmarketing study was conducted to evaluate the real‐world safety
and efficacy of an NS3‐4A protease inhibitor, telaprevir (TVR), in combination with …
and efficacy of an NS3‐4A protease inhibitor, telaprevir (TVR), in combination with …
Predictors of early treatment discontinuation and severe anemia in a Brazilian cohort of hepatitis C patients treated with first-generation protease inhibitors
N Miotto, LC Mendes, LP Zanaga… - Brazilian Journal of …, 2016 - SciELO Brasil
The aim of this study was to determine risk factors for adverse events (AE)-related treatment
discontinuation and severe anemia among patients with chronic hepatitis C virus (HCV) …
discontinuation and severe anemia among patients with chronic hepatitis C virus (HCV) …
Risk factors for severe anaemia during telaprevir-based triple therapy: is acquired renal dysfunction the missing link?
A Pariente, AJ Rémy, B Lesgourgues… - Liver …, 2014 - search.ebscohost.com
Risk factors for severe anaemia during telaprevirbased triple therapy: is acquired renal
dysfunction the missing link? Page 1 responses were then grouped and analysed in four …
dysfunction the missing link? Page 1 responses were then grouped and analysed in four …
Terapia triple en pacientes con fibrosis avanzada y cirróticos: aspectos relevantes en la práctica clínica
A Albillos, JL Calleja, E Molina, R Planas… - Gastroenterología y …, 2014 - Elsevier
El tratamiento de los pacientes con fibrosis hepática avanzada y cirrosis por el virus de la
hepatitis C en su modalidad de terapia triple con boceprevir/telaprevir e interferón pegilado …
hepatitis C en su modalidad de terapia triple con boceprevir/telaprevir e interferón pegilado …
超声造影时间**度曲线无创性定量分析代偿期肝硬化的诊断效能
范梅花， 毛**芬， 黄品同， 叶晓兰， 詹银楚 - 医学研究杂志, 2015 - yxyjzz.cn
目的分析超声造影时间**度曲线对代偿期肝硬化的诊断效能. 方法收集66 例乙型肝炎患者,
所有患者均进行超声造影并取得病理学检查结果. 根据Metavir 评分标准将所有患者分为3 组 …
所有患者均进行超声造影并取得病理学检查结果. 根据Metavir 评分标准将所有患者分为3 组 …
[PDF][PDF] リアルワールドデータ を用いた C 型肝炎治療の医療経済評価及び安全性プロファイルの検討
大澤麻衣子 - 2020 - u-shizuoka-ken.repo.nii.ac.jp
21 世紀に入り, Real World Data (RWD) の利活用が薬剤疫学的手法として行われる様になってき
た. RWD とは, 実臨床或いは実社会における患者の健康状態や治療の状況を …
た. RWD とは, 実臨床或いは実社会における患者の健康状態や治療の状況を …
Antiviral Drugs
S Othumpangat, JD Noti, SD Ray - Side Effects of Drugs Annual, 2015 - Elsevier
Abstract The Side Effects of Drugs Annuals form a series of volumes in which the adverse
effects of drugs and adverse reactions to them are surveyed. This review of the July 2013 to …
effects of drugs and adverse reactions to them are surveyed. This review of the July 2013 to …
Proving risk factors with laboratory data may be more valuable.
M Coban, E Sertoglu - Liver International, 2015 - search.ebscohost.com
Proving risk factors with laboratory data may be more valuable Page 1 Acknowledgement
Conflict of interest: The authors do not have any disclosures to report. Manuel Mai1, Peter …
Conflict of interest: The authors do not have any disclosures to report. Manuel Mai1, Peter …
[PDF][PDF] Reply to:“Renal impairment and anemia during triple therapy”
M Romero-Gómez, M Berenguer, E Molina… - Journal of …, 2014 - cyberleninka.org
[1] Romero-Gómez M, Berenguer M, Molina E, Calleja JL. Management of anemia induced
by triple therapy in patients with chronic hepatitis C: Challenges, opportunities and …
by triple therapy in patients with chronic hepatitis C: Challenges, opportunities and …